Par Pharmaceutical Companies, Inc. http://www.alacrastore.com/company-snapshot/Par_Pharmaceutical_Companies_Inc-1012836 Thursday, January 08, 2009 2:04:40 PM 1012836 Par Pharmaceutical Companies, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MW-0001-30484235newstex/MW-0001-30484235xml BOTHELL, WA, Dec. ##, #### (Marketwire delivered by Newstex) -- BOTHELL, WA -- (Marketwire) -- ##/##/## -- MDRNA, Inc. (NASDAQ: MRNA) announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval of...07000000070130001300000013007000040000000400200004002006040020010401600004016005070140000701401207014001070140170700300007003001130100001301000512/15/2008 10:22:39 AM1800000018020000180160001900000019001000MarketwireMW-0001-30484235MDRNA INC.NOVARTIS AGPAR PHARMACEUTICAL COMPANIES, INC.J MICHAEL FRENCHMRNANVSPRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-30435119newstex/PRN-0005-30435119xml WOODCLIFF LAKE, N.J., Dec. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced the resignation of Veronica A. Lubatkin, executive vice president and chief financial...0900000009015000040000000401600004016001040160080400200004002006070000000701400007014012070030000700300113000000130100001301000512/12/2008 1:19:42 PM1800000018007000PR Newswire USPRN-0005-30435119ALFACELL CORPNEOPHARM INCPAR PHARMACEUTICAL COMPANIES, INC.LAWRENCE A KENYONVERONICA LUBATKINACELNEOLPRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-30052752newstex/PRN-0005-30052752xml Dec. #, #### (PR Newswire delivered by Newstex) -- Expects to File NDA with FDA in Early to Mid-####WARREN, N.J., Dec. # /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing...0700000007013000010000000100500004000000040020000400200604010000040100010700300007003001070140000701401213000000130100001301000512/2/2008 9:31:18 AM1800000018020000180220001900000019001000PR Newswire USPRN-0005-30052752MONOSOL RX INC.PAR PHARMACEUTICAL COMPANIES, INC.MSRXPRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-30052835newstex/PRN-0005-30052835xml WOODCLIFF LAKE, N.J., Dec. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that its development partner,...0400000004002000040020060401000004010001070000000700300007003001070140000701401213000000130100001301000512/2/2008 9:31:18 AM1800000018020000180220001900000019001000PR Newswire USPRN-0005-30052835MONOSOL RX INC.PAR PHARMACEUTICAL COMPANIES, INC.John A MacPheeMSRXPRXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2004997ccbn/B2004997norm...PRX reported YTD total revenues of $###m and net loss of $##m or $#.## per diluted share. #Q## total revenues were $###m, net income was $#.#m and diluted EPS was $#.##. Expected #### diluted EPS from continuing operations to be loss from continuing operations of $#.## to income of $#.##. ... 11/7/2008 2:06:00 PMPar Pharmaceutical Companies, Inc.54.0000EditedPar Pharmaceutical Companies, Inc. Q3 2008 Earnings Conference Call SummaryPRX9:00am ETBriefB2004997Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2004997ccbn/T2004997norm...Good day ladies and gentlemen and welcome to the third quarter Par Pharmaceutical earning conference call. My name is Sandy and I'll be your coordinator for today. At at this time all participants are in listen-only mode. We will be facilitating a question-and-answer session at the end of the conference. (OPERATOR INSTRUCTIONS) As a reminder this conference is being recorded for replay purposes. I would now turn the presentation over to your host for today's conference Allison Wey, Senior Director, Investor Relations. Please proceed. ... 11/7/2008 10:06:00 AMPar Pharmaceutical Companies, Inc.54.0000FinalPar Pharmaceutical Companies, Inc. Q3 2008 Earnings Conference Call TranscriptPRX9:00am ETTranscriptT2004997Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-29320577newstex/PRN-0005-29320577xml WOODCLIFF LAKE, N.J., Nov. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced results for the third quarter ended Sept ##, ####. Third Quarter and Nine Month ResultsFor...04000000040160000401601804016048040160030401600104016013040160190400200004002006040100000401000107000000070140000701401213000000130100001301000511/6/2008 5:29:36 PM18000000180040001800800018020000180150001801200018013000PR Newswire USPRN-0005-29320577PAR PHARMACEUTICAL COMPANIES, INC.PRXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-29034591newstex/PRN-0005-29034591xml WOODCLIFF LAKE, N.J., Oct. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Friday, November #, #### at #:##...04000000040020000400200604016000040160180401604807000000070140000701401213000000130100001301000510/28/2008 2:22:25 PM180000001800400018008000PR Newswire USPRN-0005-29034591PAR PHARMACEUTICAL COMPANIES, INC.PRXNewsNewstexhttp://www.alacrastore.com/storecontent/bir/267446bir/267446normPar Pharmaceutical Companies Inc.Pharmaceutical Resources Inc.Kali Laboratories Inc.United StatesManufacturing: Generic pharmaceuticals.2834671932541255111217EJPRX9/23/2008 6:15:39 AM267446Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/B1911910ccbn/B1911910norm...PRX reported #H## total revenues of $###m and net loss of $##.#m or $#.## per diluted share. #Q## total revenues were $###m and #Q## net loss was $##.#m or $#.## per diluted share. Co. expects #### EPS from continuing operations to be a loss of $#.## to earnings of $#.## per diluted share and #H## fully diluted EPS from continuing operations of $#.##-#.##. ... 8/8/2008 2:06:00 PMPar Pharmaceutical Companies, Inc.54.0000EditedPar Pharmaceutical Companies, Inc. Q2 2008 Earnings Conference Call SummaryPRX9:00am ETBriefB1911910Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1911910ccbn/T1911910norm...Good day, ladies and gentlemen, and welcome to the second quarter #### Par Pharmaceutical's conference call. My name is Karen, and I will be your coordinated for today. At this time, all participants are in listen-only mode. We will be facilitating a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. I would now like the presentation over to your host for today's call, Ms. Allison Wey, Senior Director of Investor Relations. Please proceed.... 8/8/2008 11:06:00 AMPar Pharmaceutical Companies, Inc.54.0000FinalPar Pharmaceutical Companies, Inc. Q2 2008 Earnings Conference Call TranscriptPRX9:00am ETTranscriptT1911910Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1830325ccbn/B1830325norm...Adjusting for a $#m payment to Alfacell for the commercialization rights to ONCONASE, EPS was $#.##, vs. reported revenues of $###.#m and net income of $##.#m or $#.## per diluted share for #Q##. ... 5/9/2008 1:41:00 PMPar Pharmaceutical Companies, Inc.54.0000EditedQ1 2008 Par Pharmaceutical Companies, Inc. Earnings Conference Call SummaryPRX9:00am ETBriefB1830325Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1830325ccbn/T1830325norm...Good day, ladies and gentlemen, and welcome to Par Pharmaceutical's first-quarter #### earnings call. My name is Jasmine, and I will the operator for today. (OPERATOR INSTRUCTIONS). I would now like to turn the presentation over to your host for today's call, Ms. Allison Wey. You may proceed, ma'am. ... 5/9/2008 11:05:00 AMPar Pharmaceutical Companies, Inc.54.0000FinalQ1 2008 Par Pharmaceutical Companies, Inc. Earnings Conference Call TranscriptPRX9:00am ETTranscriptT1830325Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1778295ccbn/B1778295norm...Compares to revenues of $###.#m and income from continuing operations of $#.#m or $#.## per diluted share for ####. ... 3/3/2008 2:04:00 PMPar Pharmaceutical Companies, Inc.54.0000EditedQ4 2007 Par Pharmaceutical Companies, Inc. Earnings Conference Call SummaryPRX9:00am ETBriefB1778295Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1778295ccbn/T1778295norm...Good day, ladies and gentlemen, and welcome to the fourth-quarter and full-year #### Par Pharmaceutical Companies earnings conference call. My name is [Nikita], and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Ms. Allison Way, Senior Director of Investor Relations. Please proceed, ma'am. ... 3/3/2008 1:04:00 PMPar Pharmaceutical Companies, Inc.54.0000FinalQ4 2007 Par Pharmaceutical Companies, Inc. Earnings Conference Call TranscriptPRX9:00am ETTranscriptT1778295Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/srp/25207srp/25207norm...Address:One Ram Ridge Road, Spring Valley, New York ##### Incorporated:DelawareSIC Classification: Pharmaceutical Preparations (####) Business Description: Par Pharmaceutical Companies, Inc. develops, manufactures and distributes a broad line of generic drugs in the United States. The company also develops and manufactures in small quantities complex synthetic active pharmaceutical ingredients. Indices:Russell ####, Russell ####, S&P ### ... 2520769888P106PRX10/6/2006 12:31:00 PM25207Credit & Investment ResearchSharkRepellent.net